← Open Payments lookup

KAYLYN COOLEY: Open Payments

NPI 1275268807 · DERIDDER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$339 in 20 payments from 9 companies in 2025. Trend: 2023 $459 · 2024 $80 · 2025 $339

Food & beverage: $339
CompanyPaymentsAmount
Novo Nordisk Inc6$96
Vanda Pharmaceuticals Inc.3$53
Axsome Therapeutics, Inc.2$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$38
Xeris Pharmaceuticals, Inc.2$32
ABBVIE INC.2$30
Amgen Inc.1$16
Lilly USA, LLC1$16
Exact Sciences Corporation1$14

Products named: FANAPT, Wegovy, Auvelity, CAPLYTA, Ozempic, GVOKE HYPOPEN, VRAYLAR, OTEZLA.

Industry payments across LA — which companies pay providers there.